A Fas(hi) Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation

Frontiers in Immunology
Soraya Maria MenezesJohan Van Weyenbergh


Human T-cell lymphotropic virus (HTLV)-1 was the first human retrovirus to be associated to cancer, namely adult T-cell leukemia (ATL), but its pathogenesis remains enigmatic, since only a minority of infected individuals develops either ATL or the neuroinflammatory disorder HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). A functional FAS -670 polymorphism in an interferon (IFN)-regulated STAT1-binding site has been associated to both ATL and HAM/TSP susceptibility. Fas(hi) T stem cell memory (Tscm) cells have been identified as the hierarchical apex of ATL, but have not been investigated in HAM/TSP. In addition, both FAS and STAT1 have been identified in an IFN-inducible HAM/TSP gene signature, but its pathobiological significance remains unclear. We comprehensively explored Fas expression (protein/mRNA) and function in lymphocyte activation, apoptosis, proliferation, and transcriptome, in PBMC from a total of 47 HAM/TSP patients, 40 asymptomatic HTLV-1-infected individuals (AC), and 58 HTLV-1 -uninfected healthy controls. Fas surface expression followed a two-step increase from HC to AC and from AC to HAM/TSP. In HAM/TSP, Fas levels correlated positively to lymphocyte activation markers, but negatively to...Continue Reading


Mar 1, 1994·The Journal of Experimental Medicine·T Suda, S Nagata
Dec 1, 1996·Journal of Neuroimmunology·H IchikawaM Iwata
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Oct 26, 2000·Nature·P H Krammer
Jan 17, 2002·The Journal of Pathology·Tineke TimmerSteven de Jong
May 23, 2002·The Journal of Infectious Diseases·Rosangela G LimaDumith Chequer Bou-Habib
Jul 20, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Janeusa PrimoAchiléa L Bittencourt
Sep 13, 2005·Oncogene·Charles R M Bangham, Mitsuhiro Osame
Mar 23, 2007·The Lancet Infectious Diseases·Kristien VerdonckEduardo Gotuzzo
Sep 7, 2007·Annals of the New York Academy of Sciences·Anat AchironMichael Gurevich
Jan 5, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lourdes FarreAchiléa L Bittencourt
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Daniela SaggioroVincenzo Ciminale
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Karen L WoodAndrea I Doseff
Sep 20, 2011·Nature Medicine·Luca GattinoniNicholas P Restifo
Oct 15, 2011·Blood·Stéphane OlindoLuc Willems
Apr 17, 2012·Autoimmunity Reviews·C ComiU Dianzani
Nov 20, 2012·Frontiers in Microbiology·Antoine Gessain, Olivier Cassar
Jul 23, 2013·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Olga BarcaVíctor M Arce
Mar 31, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Davi TanajuraEdgar M Carvalho
Mar 31, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Graham P Taylor
Apr 8, 2015·Blood·Yuya NagaiAkifumi Takaori-Kondo
Jan 1, 2015·Nature Reviews. Disease Primers·Charles R M BanghamGraham P Taylor


Nov 18, 2018·Frontiers in Immunology·Jesse W WilliamsAnne I Sperling
Aug 28, 2019·International Journal of Molecular Sciences·Giovanna C CavalcanteÂndrea Ribeiro-Dos-Santos
Jan 31, 2018·Frontiers in Microbiology·Antonio C R VallinotoRicardo Ishak
Apr 12, 2021·Neurology. Clinical Practice·Gabriela PratesJorge Casseb

Datasets Mentioned


Methods Mentioned

density gradient centrifugation
flow cytometry
fluorescence microscopy

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.


Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.